NOX 1.45% 6.8¢ noxopharm limited

It is worth stressing that the FDA has allowed the use of...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    It is worth stressing that the FDA has allowed the use of Veyonda as a first line treatment. That is highly unusual for experimental drugs. Normally you are restricted to testing your drug on end-stage patients who have failed other therapies. The clinicians must have wanted this because of the very poor response rate to doxorubicin, and that is the best they have.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
-0.001(1.45%)
Mkt cap ! $19.87M
Open High Low Value Volume
6.8¢ 6.8¢ 6.6¢ $10.20K 152.8K

Buyers (Bids)

No. Vol. Price($)
2 51263 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 59000 1
View Market Depth
Last trade - 12.52pm 27/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.